T3 Companies’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
T3 Companies's PYXS Position: Q3 2026 in Review
T3 Companies opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 26,100 shares worth $60.8K. The stake represents 0.06% of the portfolio and ranks #128 among its holdings.
101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- T3 Companies held 26,100 shares of Pyxis Oncology worth $60.8K as of Q3 2026.
- Pyxis Oncology was a new T3 Companies position in Q3 2026.
- Pyxis Oncology made up 0.06% of T3 Companies's portfolio in Q3 2026, its #128 holding.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on T3 Companies's 13F filing for Q3 2026, filed 22 Oct 2026.